Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 3Non-squamous Non-small Cell Lung Cancer 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Breast Neoplasms 2Lung Neoplasms 1Liver Neoplasms 1Esophageal Squamous Cell Carcinoma 1ESCC 1Desmoid Tumors 1Advanced Solid Tumor 1

Interventions

tislelizumab 1anlotinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Solid Tumor × anlotinib × Clear all
NCT03929965 2019-04-29

Anlotinib in Advanced Solid Tumors With FGFR Alteration

Shanghai Changzheng Hospital

Phase NA Unknown
30 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡